Opinion

Video

Retrospective Claims Data and Patient Reported-Outcomes from COMMANDS Trial in Lower-Risk MDS

Author(s):

Andrew Brunner, MD,Amy DeZern, MD, MHS

Amy DeZern, MD, MHS, discusses a retrospective study on healthcare claims for patients with MDS treated with luspatercept and reviews patient-reported outcomes from the COMMANDS trial.

Related Videos
Minoo Battiwalla, MD, MS
Leo I. Gordon, MD
Farrukh Awan, MD, discusses treatment considerations with the use of pirtobrutinib in previously treated patients with hematologic malignancies.
5 KOLs are featured in this series.
Related Content
LBS-007 receives fast track status from the FDA for use in patients with acute myeloid leukemia.
December 3rd 2024

FDA Awards Fast Track Designation to LBS-007 for Acute Myeloid Leukemia

Paul J. Shaughnessy, MD, medical director, Adult Blood and Marrow Stem Cell Transplant Program, Methodist Hospital
November 28th 2024

FDA Approval Insights: Obe-Cel in B-Cell Precursor ALL

November Recap
December 2nd 2024

Revisit Every OncLive On Air Episode From November 2024

D. Ross Camidge, MD, PhD; Chaplain Rhonda Cooper, primary chaplain, Johns Hopkins Sidney Kimmel Cancer Center
June 13th 2024

Camidge and Cooper on Finding Purpose and Embracing Nuance in Hospital Chaplaincy

Leo I. Gordon, MD
December 2nd 2024

Vice Chair of the B-Cell Lymphomas NCCN Guidelines Maps Critical Changes From 2024

Neil P. Shah, MD, PhD
December 1st 2024

The Addition of Asciminib and Removal of Omacetaxine Mark Notable CML NCCN Guideline Updates